.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
The C-GALL randomized trial compared conservative management with laparoscopic cholecystectomy in adults with uncomplicated symptomatic gallstone disease. The study is important because it challenges the assumption that every symptomatic gallstone patient should undergo immediate surgery. Conservative management allowed some patients to avoid an operation during follow-up, while surgery provided a more definitive treatment pathway for those with persistent or recurrent symptoms. The findings support a shared decision-making model in which clinicians discuss the natural history of gallstone symptoms, the likelihood of future problems, operative risks and the patient’s preferences. The trial applies to uncomplicated symptomatic disease, not to patients with acute cholecystitis, obstruction, pancreatitis or other clear indications for urgent intervention. For surgeons, the practical implication is that the consultation should distinguish between conditions where surgery is clearly indicated and those where a period of observation is reasonable. C-GALL adds randomized evidence to a growing literature supporting individualized treatment rather than an automatic operation based solely on the presence of gallstones.
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
The C-GALL randomized trial compared conservative management with laparoscopic cholecystectomy in adults with uncomplicated symptomatic gallstone disease. The study is important because it challenges the assumption that every symptomatic gallstone patient should undergo immediate surgery. Conservative management allowed some patients to avoid an operation during follow-up, while surgery provided a more definitive treatment pathway for those with persistent or recurrent symptoms. The findings support a shared decision-making model in which clinicians discuss the natural history of gallstone symptoms, the likelihood of future problems, operative risks and the patient’s preferences. The trial applies to uncomplicated symptomatic disease, not to patients with acute cholecystitis, obstruction, pancreatitis or other clear indications for urgent intervention. For surgeons, the practical implication is that the consultation should distinguish between conditions where surgery is clearly indicated and those where a period of observation is reasonable. C-GALL adds randomized evidence to a growing literature supporting individualized treatment rather than an automatic operation based solely on the presence of gallstones.
Yesterday
The phase 3 ACACIA-HCM trial reveals that aficamten improves cardiac structure, diastolic relaxation, functional capacity, and symptom burden in symptomatic nonobstructive hypertrophic cardiomyopathy, marking a major milestone in targeted myosin inhibition.
6 days back
A clinical study shows that automated breast ultrasound paired with artificial intelligence accurately classifies BIRADS 3-4 lesions, reaching 95% sensitivity and 79% specificity. This diagnostic advance promises to reduce unnecessary core needle biopsies and refine clinical workflows in breast imaging.
3 weeks back
Researchers have engineered freestanding hierarchical-porous BCZT thin films that resist cracking and enhance ultrasonic energy harvesting in soft tissue. Achieving high piezoelectric output and acoustic matching, this lead-free material offers transformative potential for implantable bioelectronics.
6 days back
A novel pathology-adaptive surface engineering strategy uses functionalized plasma polymer coatings to selectively modulate AGE adsorption, reducing oxidative stress and restoring bone formation in diabetic and aging microenvironments.
3 weeks back
A breakthrough study identifies the Klotho/PKCα/CUX1/SPARC/TGFβ-RII axis as a critical driver of podocyte mitochondrial injury and ferroptosis in diabetic kidney disease, unveiling promising molecular targets to halt renal disease progression.
6 days back
